About CenSyn
CenSyn is a company based in Irvine (United States) founded in 2019. CenSyn has raised $105 thousand across 1 funding round from investors including Berkeley SkyDeck. CenSyn operates in a competitive market with competitors including Ceribell, INBRAIN Neuroelectronics, Mynd Analytics, BrainScope and Beacon Biosignals, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Censyn India Private Limited
- Date of Incorporation 02 Nov, 2023
- Jurisdiction Bangalore North, Karnataka, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$105 K (USD)
in 1 rounds
-
Latest Funding Round
$105 K (USD), Seed
Sep 28, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CenSyn
CenSyn has successfully raised a total of $105K through 1 strategic funding round. The most recent funding activity was a Seed round of $105 thousand completed in September 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CenSyn
CenSyn has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Berkeley SkyDeck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Startups are accelerated and incubated across diverse industries.
|
Locked | Locked | Locked |
Investor details for CenSyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CenSyn
Investment portfolio details for CenSyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CenSyn
Detailed financials for CenSyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Censyn Comparisons
Peer comparison for CenSyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CenSyn
CenSyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ceribell, INBRAIN Neuroelectronics, Mynd Analytics, BrainScope and Beacon Biosignals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Portable EEG devices for point-of-care seizure diagnosis are provided.
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Provider of reference data and analytic tools for clinicians and researchers in psychiatry.
|
|
| Locked | Locked | Locked |
Developer of AI-driven EEG platform transforming brain electrical activity into insights
|
|
| Locked | Locked | Locked |
AI-based EEG analysis is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
Neurostimulation devices for opioid withdrawal symptoms are developed.
|
Detailed competitors of CenSyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Censyn
Complete news archive for CenSyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CenSyn
CenSyn was founded in 2019 and raised its 1st funding round 2 years after it was founded.
CenSyn is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Ayushi Patel is the current CEO of CenSyn.
CenSyn is a funded company, having raised a total of $105K across 1 funding round to date.
CenSyn was founded in 2019 in Irvine, United States, within the medical device sector focused on neurology. EEG technology is offered for rapid screening of non-convulsive seizures among neuro-ICU patients. The proprietary CenSyn PenEEG device supports immediate neurological assessments and is applied in screening for Alzheimers disease, traumatic brain injury, and epilepsy. Software integration and AI-based features facilitate remote tele-neurology monitoring.
CenSyn's top competitors include Ceribell, INBRAIN Neuroelectronics and BrainScope.
CenSyn has 1 investor. Key investors include Berkeley SkyDeck.